miR-182 regulates trastuzumab resistance by targeting MET in breast cancer cells
- Type
- Retraction
- Notice date
- 6/5/2024 0:00
- Journal
- Cancer Gene Therapy
- Publisher
- Springer - Nature Publishing Group
- Notice DOI
- 10.1038/s41417-024-00787-3
- Original paper DOI
- 10.1038/s41417-018-0031-4
Reasons
- Concerns/Issues about Data
- Euphemisms for Plagiarism
- Investigation by Journal/Publisher
- Plagiarism of Image
- Unreliable Results and/or Conclusions